It is especially important to be able to replace LA testing, when it could not be measured, with other suitable and similar marker as LA has been shown to be the strongest risk factor of thrombosis comparing to aCL and aβ2GP1 (36). The gene discussed is ACLY; the disease is deep vein thrombosis.